News & Media 23rd Apr 2026

Safeguarding the Pharma Excipients Supply Chain

Authors

Ashishchandra RaoPartner | Mumbai

Latest Thought Leadership

Alerts & Updates 17th Jun 2026

New SEBI Rules for Retention of Proceeds and ‘Inoperative Fund’ Status for AIFs

Read More
Newsletter/Booklets 16th Jun 2026

Market Matters – The Antitrust Brief – May 2026

Read More
Investment Funds
Alerts & Updates 15th Jun 2026

Draft VCC Structure For GIFT-IFSC Published by the DEA – An Analysis

Read More
Data Privacy
Alerts & Updates 11th Jun 2026

The DPDPA’s Enforcement Gap – Limited Remedies for Data Principles and Independence of the DPB

Read More

Our Partner, Ashishchandra Rao a shares his insight in Express Pharma, “Safeguarding the Pharma Excipients Supply Chain.”

He highlighted that at present,there is no specific CDSCO or Drugs Rules provision that itemises,in a detailed matter, what precise ‘details of excipients’must be provided or encoded for purposes of the QR Code Rule require ment. The amendment simply adds a requirement to capture ‘qualitative details of excipients’, without further sub-cate gorisation.Such generalisation of require ments in labeling often results in wide ambiguity as to the actual purpose for which the requirement was intended.

Read the article here

Privacy Policy

As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.